Literature DB >> 12649412

Serotonin reuptake inhibitors, Raynaud's phenomenon and erythromelalgia.

J Rey, E Cretel, R Jean, M-J Pastor, J-M Durand.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12649412     DOI: 10.1093/rheumatology/keg137

Source DB:  PubMed          Journal:  Rheumatology (Oxford)        ISSN: 1462-0324            Impact factor:   7.580


× No keyword cloud information.
  5 in total

1.  Citalopram-induced Raynaud's phenomenon.

Authors:  A M Peiró; C Margarit; M Torra
Journal:  Rheumatol Int       Date:  2006-11-14       Impact factor: 2.631

Review 2.  Drug-induced Raynaud's phenomenon: beyond β-adrenoceptor blockers.

Authors:  Charles Khouri; Sophie Blaise; Patrick Carpentier; Céline Villier; Jean-Luc Cracowski; Matthieu Roustit
Journal:  Br J Clin Pharmacol       Date:  2016-04-07       Impact factor: 4.335

3.  [Erythromelalgia: skin redness and pain].

Authors:  M Dusch; M Schmelz
Journal:  Schmerz       Date:  2019-10       Impact factor: 1.107

Review 4.  Advances in the treatment of Raynaud's phenomenon.

Authors:  Terri L Levien
Journal:  Vasc Health Risk Manag       Date:  2010-03-24

Review 5.  Raynaud's Phenomenon: Reviewing the Pathophysiology and Management Strategies.

Authors:  Iqra Nawaz; Yashfa Nawaz; Eisha Nawaz; Muhammad Romail Manan; Adil Mahmood
Journal:  Cureus       Date:  2022-01-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.